Contact us here

Core Outcome Sets

PIONEER Prostate Cancer Core Outcome Sets

The PIONEER Core Outcome Sets (COSs) for Localised, Locally Advanced, Metastatic, and Non-metastatic Castration-resistant Prostate Cancer are the result of a methodological rigorous systematic review and consensus finding process with a diverse range of prostate cancer stakeholders including clinicians, nurses, researchers, industry partners and most importantly patients.

The PIONEER Prostate Cancer COSs have also been endorsed by the European Association of Urology, Europe’s leading medical authority on urological practice, research, and education. A reflection on the importance of COS for the advancement of clinical practice.

The PIONEER Prostate Cancer COSs are a continually evolving resource. They represent a minimum set of outcomes, which can be amended with defendable justification, depending on clinical setting and changes in the treatment landscape. Therefore, we would highly encourage everybody to start measuring these outcomes to improve treatment and care for prostate cancer patients.

Consensus Definitions PIONEER Core Outcome Sets

Localised Prostate Cancer

Metastatic Prostate Cancer

Clinician Reported

Core Outcome Sets: What they are & why they are important

PIONEER Disease Understanding Work Package

Listen to Dr. Steven MacLennan and Prof. Mieke Van Hemelrijck explain what core outcome sets are and why they are important. Followed by Dr. Elena Sisca and Dr. Monica Ratti discussing patient reported outcome measures and their impact on clinical research and patient care.